Studies
Studies
Operating Room (O.R.) Study
4 operating rooms in a tertiary medical center were sampled three times over a 6-week period. The operating rooms included two general surgical disinfectants in the operating room environment using O.R., a hybrid O.R. where open and endovascular procedures are performed, and an O.R. used for kidney and liver transplants.
Assessment of an innovative antimicrobial surface disinfectant in the operating room environment using adenosine triphosphate bioluminescence assay. Lewis, B – Spenser, M – Rossi, P – et. al. – Am J Infect Control, Vol 43, p283-285.
%
Percentage of terminally cleaned O.R. surfaces tested culture-positive with heavy bacterial contamination before being treated with MicrobeCare™.
Dr. Charles E. Edmiston Jr.
PhD, SM (ASCP), CIC (CBIC), FIDSA, FSHEA, FABIC
He is the emeritus Professor of Surgery at the Medical College of Wisconsin and serves as consultant to the Hospital Infection Control Practice Advisory Committee (HICPAC) of the Centers of Disease Control and Prevention.
%
Percentage of O.R. surfaces tested were culture-negative 6 weeks after treatment. Of the surfaces that were culture-positive, the mean colony count after 6 weeks for treated surfaces was 0.8 cfu, compared to 14.3 cfu of untreated surfaces.
%
Percentage reduction in ATP scores 6 weeks after treating O.R. surfaces with MicrobeCare™. The mean ATP score after 6 weeks untreated resulted with a surface of 279.9 RLU compared to 75.9 RLU of treated surfaces.
Intensive Care Unit (I.C.U.) Study
Selective high touch surfaces in a 26-bed medical intensive care unit at a tertiary medical center were sampled over a 6-week period. The sample sites included telephone handpieces, computer keypads, surfaces of physician workstations, and selective patient items (blood pressure cuffs and patient bed tables).
Assessment of a novel antimicrobial surface disinfectant on inert surfaces in the intensive car unit environment using ATP-bioluminescence assay. Lewis, B – Spenser, M – et. al. – Am J Infect Control.
%
Percentage of surfaces that were assessed as “dirty” before being treated with MicrobeCare™.
Nontreated I.C.U. sampling sites yielded multiple Gram-positive and Gram-negative microbial isolates, including multidrug resistant strains of MRSA and extended spectrum betalactamanse Gram-negative pathogens.
%
Percentage of I.C.U. surfaces tested culture-negative 6 weeks after treatment. Of the surfaces that were culture-positive, the mean colony count after 6 weeks for treated surfaces was 0.83 cfu compared to 51 cfu of untreated surfaces.
%
Percentage reduction in ATP scores 6 weeks after treating high touch surfaces with MicrobeCare™. The mean ATP score after 6 weeks untreated resulted with a surface of 327.6 RLU compared to 44.7 RLU of treated surfaces.
Stethoscope Study
A baseline study was conducted at a150 bed hospital. 70 stethoscopes were sampled prior to being treated with MicrobeCare™. The stethoscopes were retested 107-days following a single application of MicrobeCare™.
There was 100 times more contamination on untreated stethoscopes than stethoscopes treated with MicrobeCare™ 90 days after treatment.
%
Percentage of untreated stethoscopes that were culture-positive with heavy bacterial contamination.
%
Percentage reduction in ATP scores 90 days after a single application of MicrobeCare™. The mean ATP score after 90 days untreated resulted with a surface of 288.4 RLU compared to 45.5 RLU of treated surfaces.
100x